Anti-Snoring Devices for Simple Snoring Without OSA
For adults with simple snoring and no obstructive sleep apnea, custom-made, titratable mandibular advancement devices (MADs) are the recommended first-line non-invasive treatment option. 1, 2
Primary Recommendation: Mandibular Advancement Devices
Custom, titratable MADs are strongly preferred over non-custom devices for treating primary snoring. These devices work by stabilizing the lower jaw in a forward and downward position, maintaining airway patency during sleep and reducing vibration of soft tissues that produce snoring sounds 1, 2.
Key Evidence Supporting MADs:
Custom devices outperform non-custom alternatives: The evidence demonstrates that custom, titratable oral appliances reduce snoring frequency and intensity significantly more than non-custom devices, with considerably smaller confidence intervals for treatment effects 2
Effectiveness for primary snoring: MADs achieve approximately 50-70% reduction in snoring across multiple studies, with improvements in both objective measurements and subjective patient/partner satisfaction 3
Better adherence than alternatives: Patients demonstrate greater long-term adherence with custom MADs compared to other treatment modalities, making them practical for sustained use 1, 2
Important Contraindications to Screen For:
Before prescribing MADs, evaluate for:
- Severe periodontal disease
- Severe pre-existing temporomandibular disorders (TMD)
- Inadequate dentition or implant retention
- Severe gag reflex
- Poor hand dexterity that would compromise device handling 1
Devices NOT Recommended
Popular over-the-counter snoring aids lack evidence of efficacy. A prospective randomized trial found no objective or subjective benefit from commonly marketed products including:
- Oral spray lubricants
- Nasal strips designed to maintain nasal valve patency
- Head-positioning pillows
These showed no significant changes in palatal snoring, loudness, flutter frequency, or respiratory disturbance index compared to no treatment 4.
Emerging Options (Limited Evidence)
Non-Invasive Electrical Stimulation Devices
New intraoral electrical stimulation devices (such as eXciteOSA) show promise for snoring reduction, with approximately 50% improvement after device training in recent studies 5. However, this technology is still emerging with limited long-term data, making it a secondary consideration rather than first-line therapy.
Oropharyngeal Myofunctional Therapy
Exercises targeting oral cavity and oropharyngeal structures may be considered as adjunctive therapy, particularly for patients who also want to address tongue positioning and mandibular development 1, 6. This should complement, not replace, MAD therapy.
Clinical Pathway
Confirm diagnosis: Ensure the patient has simple snoring without OSA (requires sleep study if OSA suspected based on symptoms, witnessed apneas, or comorbidities) 1, 6
Dental evaluation: Refer to a dentist trained in dental sleep medicine for assessment of contraindications and fitting of custom, titratable MAD 1, 2
Titration: The device should be adjusted to achieve 50-70% of maximum mandibular protrusion for optimal efficacy 3
Monitor side effects: Most common are temporomandibular joint pain and excessive salivation, which typically improve with time 3
Follow-up: Regular monitoring for device effectiveness, side effects, and dental/TMJ changes 1
Critical Pitfall to Avoid
Do not use non-custom, over-the-counter oral devices. The evidence clearly demonstrates inferior outcomes compared to custom-fitted appliances, with wider confidence intervals for treatment effects and lower patient adherence 2. The modest cost savings are offset by poor effectiveness and higher discontinuation rates.